Variant report
Variant | nsv525560 |
---|---|
Chromosome Location | chr12:73129586-73140752 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537955110 | chr12:73131407-73131408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs549769630 | chr12:73131425-73131426 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs149806485 | chr12:73131439-73131440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs115147632 | chr12:73131441-73131442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs548610795 | chr12:73131442-73131443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs567047892 | chr12:73131453-73131454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs114093707 | chr12:73131467-73131468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs557704582 | chr12:73131506-73131507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558606327 | chr12:73131559-73131560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs570647620 | chr12:73131603-73131604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs542654635 | chr12:73131611-73131612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs111954681 | chr12:73131627-73131628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs574740757 | chr12:73131658-73131659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs542064230 | chr12:73131661-73131662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553822044 | chr12:73131670-73131671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs146820559 | chr12:73131675-73131676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs187060594 | chr12:73131715-73131716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs376538002 | chr12:73131764-73131765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs191118111 | chr12:73131772-73131773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs531406866 | chr12:73131784-73131785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs180787891 | chr12:73131804-73131805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs577628592 | chr12:73131810-73131811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs572264848 | chr12:73131819-73131820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs543546057 | chr12:73131828-73131829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs561628390 | chr12:73131865-73131866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs186709323 | chr12:73131889-73131890 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs548862857 | chr12:73131899-73131900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs567081694 | chr12:73131913-73131914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs551215627 | chr12:73131931-73131932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs112677197 | chr12:73131946-73131947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs554193941 | chr12:73131994-73131995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs140325649 | chr12:73132008-73132009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs570730414 | chr12:73132034-73132035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs537899405 | chr12:73132073-73132074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs556246522 | chr12:73132079-73132080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs145453106 | chr12:73132092-73132093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs190075164 | chr12:73132096-73132097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs12297767 | chr12:73132107-73132108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs542891828 | chr12:73132108-73132109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs554010828 | chr12:73132141-73132142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs572284994 | chr12:73132151-73132152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs564300875 | chr12:73132161-73132162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs183046751 | chr12:73132174-73132175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs138085810 | chr12:73132194-73132195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs112681909 | chr12:73132205-73132206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs143025828 | chr12:73132214-73132215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs187370987 | chr12:73132223-73132224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs190337893 | chr12:73132233-73132234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs528861047 | chr12:73132257-73132258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs117564197 | chr12:73132265-73132266 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 16620391 | CNVD |
Disease | 21505450 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 20685689 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 22032731 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:73131400-73131600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr12:73131400-73131800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr12:73131600-73132800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr12:73132000-73132600 | Enhancers | Primary hematopoietic stem cells | blood |
5 | chr12:73132000-73132800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
6 | chr12:73132000-73134600 | Enhancers | Primary monocytes fromperipheralblood | blood |
7 | chr12:73132200-73132800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
8 | chr12:73132600-73133600 | Weak transcription | Primary hematopoietic stem cells | blood |
9 | chr12:73132600-73134400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
10 | chr12:73133600-73133800 | ZNF genes & repeats | Primary hematopoietic stem cells | blood |
11 | chr12:73134200-73134600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr12:73134400-73134800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
13 | chr12:73134600-73140600 | Weak transcription | Primary monocytes fromperipheralblood | blood |
14 | chr12:73140600-73143200 | Enhancers | Primary monocytes fromperipheralblood | blood |